Asha Anand
Overview
Explore the profile of Asha Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anand A, Mahadevappa S, Ojha R, Pal A, Priya S, Dsouza A, et al.
Arch Virol
. 2025 Mar;
170(4):73.
PMID: 40080142
Peste des petits ruminants (PPR) is a highly contagious disease affecting sheep and goats, caused by PPR virus (PPRV), a member of the genus Morbillivirus. In 2023 and 2024, on...
2.
Anand A, Chauhan S, Chodon A, Vimala Kumar K, Saravanakumar S, Pandi G
BioTechnologia (Pozn)
. 2024 Apr;
105(1):19-32.
PMID: 38633894
The microRNAs are endogenous, regulating gene expression either at the DNA or RNA level. Despite the availability of extensive studies on microRNA generation in plants, reports on their abundance, biogenesis,...
3.
Anand A, Hildebrandt C, Shenoy V, Sutherland R
Am J Med Genet A
. 2024 Jan;
194(5):e63526.
PMID: 38192228
Congenital anomalies of the kidney and urinary tract (CAKUT) are estimated to be responsible for 20%-50% of congenital anomalies and are also a leading etiology of early-onset renal disease. Primary...
4.
Saxena M, Madabhavi I, Patel A, Panchal H, Anand A
J Cancer Res Ther
. 2023 Oct;
19(5):1371-1378.
PMID: 37787311
Background: Acute promyelocytic leukemia (APL) comprises approximately 10% of acute myeloid leukemia (AML) cases. Material And Methods: Both options of treatment (ATRA-ATO and ATRA-chemotherapy) were discussed with patients with low-...
5.
Anand A, Ghosh P, Singh R, Bajad N, Kumar A, Singh S
J Biomol Struct Dyn
. 2023 Jun;
42(9):4679-4698.
PMID: 37306006
Histone deacetylase 2 (HDAC2) is associated with various neuropathic degenerative diseases and is considered a novel target for Alzheimer's disease (AD). Elevated levels of HDAC2 trigger excitatory neurotransmission and reduce...
6.
Madabhavi I, Patel A, Anand A, Panchal H
J Cancer Res Ther
. 2023 Apr;
19(2):335-339.
PMID: 37006069
Background: Imatinib has changed the treatment of chronic myeloid leukemia (CML) drastically since 15 years. It is usually well tolerated, but severe persistent marrow aplasia is an unusual complication of...
7.
Patel J, Garg A, Patel K, Shah K, Shah S, Yadav R, et al.
Indian J Hematol Blood Transfus
. 2022 Jun;
38(3):585-590.
PMID: 35747573
Nivolumab is an anti-programmed cell death protein 1 (PD1) monoclonal antibody that is indicated in relapsed/refractory Hodgkin lymphoma (R/R HL) after autologous stem cell transplant (autoSCT). Purpose of our retrospective...
8.
Sohal A, Anand A, Kaur P, Kaur H, Attri J
Anesth Essays Res
. 2021 Oct;
15(1):8-13.
PMID: 34667341
Introduction: Acute respiratory failure is a potential complication of chronic obstructive pulmonary disease (COPD) that severely affects the health of the patient and may require mechanical ventilation. We compared noninvasive...
9.
Kiran M, Misra S, Pr S, Babu S, Anand A, Koshy T
J Cardiothorac Vasc Anesth
. 2021 May;
36(1):202-207.
PMID: 34006468
Objectives: The primary objective of this study was to establish "normal" right atrial (RA)-indexed end-systolic volumes (ESVs) and emptying fraction (EF) in children undergoing ventricular septal defect (VSD) repair using...
10.
Singh B, Anand A, Attri J
Anesth Essays Res
. 2021 Jan;
14(2):266-270.
PMID: 33487827
Background: For an outpatient surgery, an ideal anesthetic drug should have a faster onset and shorter duration of action and minimal side effects. Although Bupivacaine is a drug of choice...